BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22026458)

  • 1. Glypican-3 is a marker for solid pseudopapillary neoplasm of the pancreas.
    Hav M; De Potter A; Ferdinande L; Van Bockstal M; Lem D; Eav S; Pattyn P; Praet M; Cuvelier C; Libbrecht L
    Histopathology; 2011 Dec; 59(6):1278-9. PubMed ID: 22026458
    [No Abstract]   [Full Text] [Related]  

  • 2. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours.
    Preda O; Nicolae A; Aneiros-Fernández J; Borda A; Nogales FF
    Histopathology; 2011 Jan; 58(2):312-4; author reply 314-5. PubMed ID: 21255065
    [No Abstract]   [Full Text] [Related]  

  • 3. The clear cell variant of solid pseudopapillary tumor of the pancreas: a previously unrecognized pancreatic neoplasm.
    Albores-Saavedra J; Simpson KW; Bilello SJ
    Am J Surg Pathol; 2006 Oct; 30(10):1237-42. PubMed ID: 17001153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Solid-pseudopapillary tumor of the pancreas in a 9-year-old girl].
    Meyer S; Aliani S; Graf N; Bonkhoff H; Schneider G; Reinhard H
    Klin Padiatr; 2002; 214(5):316-8. PubMed ID: 12235551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid pseudopapillary tumor of the pancreas: emphasis on differential diagnosis from aggressive tumors of the pancreas.
    Aydiner F; Erinanç H; Savaş B; Erden E; Karayalçin K
    Turk J Gastroenterol; 2006 Sep; 17(3):219-22. PubMed ID: 16941259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
    Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
    Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid pseudopapillary tumor of the pancreas: clinical analysis of 11 cases.
    Yu P; Cheng X; Guo J; Wang X; Zhang Y
    Hepatogastroenterology; 2011; 58(105):192-7. PubMed ID: 21510313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of solid-pseudopapillary tumor of the pancreas: preoperative cyst fluid analysis and treatment by enucleation.
    Ashton J; Sutherland F; Nixon J; Nayak V
    Hepatogastroenterology; 2003; 50(54):2239-41. PubMed ID: 14696507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.
    Hav M; Lem D; Chhut SV; Kong R; Pauwels P; Cuvelier C; Piet P
    Malays J Pathol; 2009 Dec; 31(2):137-41. PubMed ID: 20514858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.
    Thway K; Selfe J; Missiaglia E; Fisher C; Shipley J
    J Clin Pathol; 2011 Jul; 64(7):587-91. PubMed ID: 21493758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-pseudopapillary tumor of the pancreas: a neoplasm with distinct and highly characteristic cytological features.
    Pettinato G; Di Vizio D; Manivel JC; Pambuccian SE; Somma P; Insabato L
    Diagn Cytopathol; 2002 Dec; 27(6):325-34. PubMed ID: 12451561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Marker behavior of pancreatic neoplasms transplanted into the nude mouse].
    Wittekind C; Fiebig HH; Furtwängler I; von Kleist S
    Verh Dtsch Ges Pathol; 1987; 71():303-5. PubMed ID: 3439325
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential.
    Klimstra DS; Wenig BM; Heffess CS
    Semin Diagn Pathol; 2000 Feb; 17(1):66-80. PubMed ID: 10721808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and morphological characteristics of solid pseudopapillary tumors of the pancreas].
    Shchegolev AI; Dubova EA; Mishnev OD
    Arkh Patol; 2009; 71(1):23-8. PubMed ID: 19514354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-cystic solid-pseudopapillary tumor of the pancreas showing nuclear accumulation and activating gene mutation of beta-catenin.
    Nishimori I; Kohsaki T; Tochika N; Takeuchi T; Minakuchi T; Okabayashi T; Kobayashi M; Hanazaki K; Onishi S
    Pathol Int; 2006 Nov; 56(11):707-11. PubMed ID: 17040296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid pseudopapillary tumor and wnt signaling pathway ... Way to go!?
    Sikora SS; Vali S
    J Gastroenterol Hepatol; 2011 Feb; 26(2):215-7. PubMed ID: 21261709
    [No Abstract]   [Full Text] [Related]  

  • 19. Glypican-3 immunostaining significantly improves histological diagnosis of hepatocellular carcinoma.
    Honsová E; Lodererová A; Franková S; Oliverius M; Trunecka P
    Cas Lek Cesk; 2011; 150(1):37-40. PubMed ID: 21400962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovered on gastrointestinal stromal tumor 1 (DOG1) is expressed in pancreatic centroacinar cells and in solid-pseudopapillary neoplasms--novel evidence for a histogenetic relationship.
    Bergmann F; Andrulis M; Hartwig W; Penzel R; Gaida MM; Herpel E; Schirmacher P; Mechtersheimer G
    Hum Pathol; 2011 Jun; 42(6):817-23. PubMed ID: 21295818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.